Douglas E. Giordano
CIK 1431552 · last filed 2024-08-05
Douglas E. Giordano is a corporate insider who has filed 7 SEC Form 4 insider transactions across 4 companies since 2013. Across all open-market trades the lifetime net is +$130.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $397.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$397.8K
4
7
$130.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 13,743 | $44.96 | $617.9K | $0 | 3 | 2024-06-07 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | — | $18.07 | — | $0 | 1 | 2021-06-14 |
| VTRS | Director | — | $16.48 | — | $0 | 1 | 2020-11-16 |
| ZTS | Director | 5,000 | $79.57 | $397.8K | $130.0K | 1 | 2013-02-08 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-05 | — | Disp (D) | −13,743 | $0 | |
| 2024-06-07 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | +10,461 | $0 | EDGAR |
| 2023-06-09 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | +3,282 | $0 | EDGAR |
| 2022-06-16 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-16 | VTRS | — | — | $0 | EDGAR |
| 2013-02-08 | ZTS | Buy (P) | +5,000 | $130.0K | EDGAR |